Literature DB >> 16687277

Melatonin and human rhythms.

Josephine Arendt1.   

Abstract

Melatonin signals time of day and time of year in mammals by virtue of its pattern of secretion, which defines 'biological night.' It is supremely important for research on the physiology and pathology of the human biological clock. Light suppresses melatonin secretion at night using pathways involved in circadian photoreception. The melatonin rhythm (as evidenced by its profile in plasma, saliva, or its major metabolite, 6-sulphatoxymelatonin [aMT6s] in urine) is the best peripheral index of the timing of the human circadian pacemaker. Light suppression and phase-shifting of the melatonin 24 h profile enables the characterization of human circadian photoreception, and circulating concentrations of the hormone are used to investigate the general properties of the human circadian system in health and disease. Suppression of melatonin by light at night has been invoked as a possible influence on major disease risk as there is increasing evidence for its oncostatic effects. Exogenous melatonin acts as a 'chronobiotic.' Acutely, it increases sleep propensity during 'biological day.' These properties have led to successful treatments for serveal circadian rhythm disorders. Endogenous melatonin acts to reinforce the functioning of the human circadian system, probably in many ways. The future holds much promise for melatonin as a research tool and as a therapy for various conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687277     DOI: 10.1080/07420520500464361

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  69 in total

Review 1.  Night Shift Work and Risk of Breast Cancer.

Authors:  Johnni Hansen
Journal:  Curr Environ Health Rep       Date:  2017-09

2.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 3.  Circadian disruption: What do we actually mean?

Authors:  Céline Vetter
Journal:  Eur J Neurosci       Date:  2018-12-05       Impact factor: 3.386

4.  The Development of Circadian Rhythms: From Animals To Humans.

Authors:  Scott A Rivkees
Journal:  Sleep Med Clin       Date:  2007-09-01

5.  Alterations of the cortisol quiescent period after experimental night work with enforced adaptation by bright light and its relation to morningness.

Authors:  Barbara Griefahn; Sibylle Robens
Journal:  Eur J Appl Physiol       Date:  2010-03       Impact factor: 3.078

6.  Long-term effects of melatonin on quality of life and sleep in haemodialysis patients (Melody study): a randomized controlled trial.

Authors:  Marije Russcher; Birgit C P Koch; J Elsbeth Nagtegaal; Frans J van Ittersum; Pieternel C M Pasker-de Jong; E Chris Hagen; Wim Th van Dorp; Bas Gabreëls; Thierry X Wildbergh; Monique M L van der Westerlaken; Carlo A J M Gaillard; Piet M Ter Wee
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

Review 7.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

8.  Altered sleep architecture and higher incidence of subsyndromal depression in low endogenous melatonin secretors.

Authors:  Shadab Ataur Rahman; Shai Marcu; Leonid Kayumov; Colin Michael Shapiro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-12-18       Impact factor: 5.270

Review 9.  Keeping Up With the Clock: Circadian Disruption and Obesity Risk.

Authors:  Naima Covassin; Prachi Singh; Virend K Somers
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

10.  Plasma melatonin circadian rhythm disturbances during pregnancy and postpartum in depressed women and women with personal or family histories of depression.

Authors:  Barbara L Parry; Charles J Meliska; Diane L Sorenson; Ana M Lopez; Luis F Martinez; Sara Nowakowski; Jeffrey A Elliott; Richard L Hauger; Daniel F Kripke
Journal:  Am J Psychiatry       Date:  2008-10-01       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.